{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:17:13Z","timestamp":1793902633706,"version":"4.8.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jhep.2022.10.013","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T14:41:23Z","timestamp":1684334483000},"page":"1147-1156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of living donors for hereditary liver disease (siblings, heterozygotes)"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1651-0430","authenticated-orcid":false,"given":"Mureo","family":"Kasahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny C.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.10.013_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00000658-199009000-00015","article-title":"Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants","volume":"212","author":"Broelsh","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2022.10.013_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.32223","article-title":"European Liver Transplant Registry: donor and transplant surgery aspects of 16,641 liver transplantation in children","volume":"75","author":"de Ville de Goyet","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000658-199301000-00014","article-title":"Surgical techniques and innovations in living related liver transplantation","volume":"217","author":"Tanaka","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2022.10.013_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13578","article-title":"Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor\u2013dominant program","volume":"23","author":"Kasahara","year":"2019","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nrgastro.2013.194","article-title":"Why does living donor liver transplantation flourish in Asia?","volume":"10","author":"Chen","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.10.013_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/TP.0000000000003154","article-title":"Pediatric living donor liver transplant in Indonesia's national referral hospital","volume":"104","author":"Oswari","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib7","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/SLA.0000000000004047","article-title":"The largest single center report on pediatric liver transplantation: experiences and lessons learned","volume":"273","author":"Nikeghbalian","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2022.10.013_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/TP.0000000000003891","article-title":"The concept of functional graft size: an eternal thema of maximizing donor safety and recipient survival in living donor liver transplantation","volume":"106","author":"Hashimoto","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/lt.23575","article-title":"Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey","volume":"19","author":"Cheah","year":"2013","journal-title":"Liver Transp"},{"key":"10.1016\/j.jhep.2022.10.013_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.27191","volume":"60","author":"Squires","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4254\/wjh.v13.i10.1351","article-title":"Liver transplantation for pediatric inherited metabolic liver diseases","volume":"13","author":"Vimalesvaran","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2022.10.013_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ymgme.2014.01.006","article-title":"Liver transplantation for pediatric metabolic disease","volume":"111","author":"Mazariegos","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jhep.2022.10.013_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/petr.12741","article-title":"Liver transplantation for pediatric inherited metabolic disorders: considerations for indications, complications, and perioperative management","volume":"20","author":"Oishi","year":"2016","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/lt.25433","article-title":"Evolving trends in liver transplant for metabolic liver disease in the United States","volume":"25","author":"McKiernan","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib15","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1097\/TP.0000000000003610","article-title":"Outcomes of pediatric liver transplantation in Japan: a report from the Japanese Liver Transplantation Society (JLTS)","volume":"105","author":"Kasahara","year":"2021","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jhep.2022.10.013_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MOT.0000000000000990","article-title":"Marginal parental donors for pediatric living donor liver transplantation","volume":"27","author":"Kasahara","year":"2022","journal-title":"Curr Opin Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/lt.23546","article-title":"Living donor liver transplantation using grafts with hepatic cysts","volume":"18","author":"Sakamoto","year":"2012","journal-title":"Liver Transp"},{"key":"10.1016\/j.jhep.2022.10.013_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25739","article-title":"Longterm survival after liver transplantation for autoimmune hepatitis: results from the European liver transplant registry","volume":"26","author":"Heinemann","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajmg.1320390226","article-title":"Estimated frequency of urea cycle enzymopathies in Japan","volume":"39","author":"Nagata","year":"1991","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jhep.2022.10.013_bib21","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM198406073102304","article-title":"Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies","volume":"310","author":"Msall","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jimd.12384","article-title":"Long-term outcome of urea cycle disorders: report from a nationwide study in Japan","volume":"44","author":"Kido","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2022.10.013_bib23","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa066596","article-title":"Survival after treatment with phenylacetate and benzoate for urea-cycle disorders","volume":"356","author":"Enns","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3476(89)80843-1","article-title":"Liver transplantation for ornithine transcarbamylase deficiency in a girl","volume":"115","author":"Largilliere","year":"1989","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhep.2022.10.013_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0022-3468(95)90766-1","article-title":"Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy","volume":"30","author":"Hasegawa","year":"1995","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.jhep.2022.10.013_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12848","article-title":"Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors","volume":"21","author":"Rahayatri","year":"2017","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib27","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1111\/j.1399-3046.2012.01716.x","article-title":"Living donor liver transplantation from an asymptomatic mother who has a carrier for ornithine transcarbamylase deficiency","volume":"16","author":"Wakiya","year":"2012","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib28","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/j.1600-6143.2005.01084.x","article-title":"Living donor liver transplantation for pediatric patients with inheritable metabolic disorders","volume":"5","author":"Morioka","year":"2005","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib29","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MPG.0b013e318282aa3b","article-title":"Late-onset ornithine transcarbamylase deficiency presenting with asymptomatic liver dysfunction","volume":"58","author":"Nightingale","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.jhep.2022.10.013_bib30","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/jth.15732","article-title":"Diagnosis and management of severe congenital protein C deficiency (SCPCD): communication from the SSC of the ISTH","volume":"20","author":"Minford","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jhep.2022.10.013_bib31","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jhep.2022.10.013_bib32","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1542\/peds.2009-2913","article-title":"Long-term subcutaneous protein C replacement in neonatal severe protein C deficiency","volume":"127","author":"De Kort","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2022.10.013_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ajh.24998","article-title":"Successful liver transplantation for homozygous protein C deficiency with a type II mutation using a heterozygous living related donor","volume":"93","author":"Boucher","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2022.10.013_bib34","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/biomedicines10051043","article-title":"Recent advances on familial hypercholesterolemia in children and adolescents","volume":"30","author":"Mainieri","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhep.2022.10.013_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jacl.2020.08.006","article-title":"Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)","volume":"14","author":"Underberg","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"issue":"7","key":"10.1016\/j.jhep.2022.10.013_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/14712598.2022.2090242","article-title":"Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia","volume":"22","author":"Pirillo","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jhep.2022.10.013_bib37","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJM198412273112603","article-title":"Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia","volume":"311","author":"Bilheimer","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00535-006-1765-6","article-title":"Two cases in one family of living donor liver transplantation for homozygous familial hypercholesterolemia","volume":"41","author":"Kawagishi","year":"2006","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2022.10.013_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00147-004-0791-7","article-title":"Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East","volume":"17","author":"Khalifeh","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2022.10.013_bib40","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/lt.25959","article-title":"Liver transplantation for acute intermittent porphyria","volume":"27","author":"Lissing","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib42","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib43","first-page":"593","article-title":"Prevention of manifestation of porphyrias in the field of digestive tract surgery: abnormal porphyrin metabolism and early diagnosis of acute intermittent porphyria","volume":"24","author":"Nunomura","year":"1996","journal-title":"St Marianna Med J"},{"key":"10.1016\/j.jhep.2022.10.013_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/L18-0623","article-title":"Recurrence of acute intermittent porphyria after liver transplantation","volume":"170","author":"Al-Samkari","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1346-8138.2006.00140.x","article-title":"Genetic analysis of the ferrochelatase gene in eight Japanese patients from seven families with erythropoietic protoporphyria","volume":"33","author":"Saruwatari","year":"2006","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jhep.2022.10.013_bib46","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/lt.22341","article-title":"Liver transplantation for erythropoietic protoporphyria in Europe","volume":"17","author":"Wahlin","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib47","first-page":"799","article-title":"A\u00a0case of erythropoietic protoporphyria with severe liver dysfunction","volume":"108","author":"Minagawa","year":"2011","journal-title":"Jap J Gastroenterol"},{"key":"10.1016\/j.jhep.2022.10.013_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13579","article-title":"Living donor liver transplantation in Alagille syndrome-single center experience from south Asia","volume":"23","author":"Valamparampil","year":"2019","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3476(87)80153-1","article-title":"Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases","volume":"110","author":"Alagille","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhep.2022.10.013_bib50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/lt.23437","article-title":"Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience","volume":"18","author":"Kamath","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/JMDH.S295441","article-title":"Multidisciplinary management of Alagille syndrome","volume":"15","author":"Menon","year":"2022","journal-title":"J\u00a0Multidiscip Healthc"},{"key":"10.1016\/j.jhep.2022.10.013_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00007890-199902150-00013","article-title":"Unsuspected bile duct paucity in donors for living-related liver transplantation: two case report","volume":"67","author":"Gurkan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib53","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1097\/01.TP.0000066804.33006.17","article-title":"Living-related liver transplantation for Alagille syndrome","volume":"75","author":"Kasahara","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clinre.2014.04.001","article-title":"Liver involvement in children with ciliopathies","volume":"38","author":"Rock","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2022.10.013_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(86)80073-3","article-title":"Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients","volume":"2","author":"Summerfield","year":"1986","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.10.013_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/SLA.0b013e31815cca88","article-title":"Long-term outcome of liver resection and transplantation for Caroli disease and syndrome","volume":"247","author":"Ulrich","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2022.10.013_bib57","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/lt.23546","article-title":"Living donor liver transplantation using grafts with hepatic cysts","volume":"18","author":"Sakamoto","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib58","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.crad.2011.05.008","article-title":"Imaging features of ductal plate malformations in adults","volume":"66","author":"Venkatanarasimha","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jhep.2022.10.013_bib59","series-title":"Diseases of the liver and biliary system in children","first-page":"124","article-title":"Congenital and structural abnormalities of the liver","author":"Schwarz","year":"1999"},{"key":"10.1016\/j.jhep.2022.10.013_bib60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/hep.1840140212","article-title":"Graft vs. host disease after liver transplantation in humans: a report of four cases","volume":"14","author":"Roberts","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/lt.20573","article-title":"Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching","volume":"12","author":"Kamei","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib62","article-title":"Graft-versus-host disease after pediatric liver transplantation: a diagnostic challenge","volume":"26","author":"Attats","year":"2022","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib63","first-page":"1","article-title":"Frequency of HLA-class I and class II homozygous cells in Japanese","volume":"41","author":"Inaba","year":"1995","journal-title":"Jap J Transfus Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM198907063210105","article-title":"The role of blood from HLA-homozygous donors in fetal transfusion-associated graft-versus-host disease after open-heart surgery","volume":"321","author":"Thaler","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.51.6.876","article-title":"Prospective study of liver dysfunction in pregnancy in Southwest Wales","volume":"51","author":"Ch\u2019ng","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.10.013_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AOG.0b013e31820ce2db","article-title":"Risk of venous thromboembolism during the postpartum period","volume":"117","author":"Jackson","year":"2011","journal-title":"Obset Gynecol"},{"key":"10.1016\/j.jhep.2022.10.013_bib67","doi-asserted-by":"crossref","DOI":"10.1053\/j.sempedsurg.2019.07.002","article-title":"Ethical challenges in invasive maternal-fetal intervention","volume":"28","author":"Austin","year":"2019","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.jhep.2022.10.013_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijoa.2005.10.003","article-title":"Anesthetic management of a pregnant living related liver donor","volume":"15","author":"Chen","year":"2006","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.jhep.2022.10.013_bib69","first-page":"539","article-title":"Living donor hepatectomy in a pregnant woman","volume":"54","author":"Lin","year":"2007","journal-title":"Hepatogastroenterol"},{"key":"10.1016\/j.jhep.2022.10.013_bib70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/hep.1840190307","article-title":"Liver transplantation for Wilson's disease: indications and outcome","volume":"19","author":"Schilsky","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.30911","article-title":"The prevalence of Wilson\u2019s disease: an update","volume":"71","author":"Sandahl","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/petr.12085","article-title":"Re-evaluation of the indications for liver transplantation in Wilson\u2019s disease based on the outcomes of patients referred to a transplant center","volume":"17","author":"Ohya","year":"2013","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-3046.1999.00014.x","article-title":"Living related liver transplantation from heterozygote genetic carriers to children with Wilson\u2019s disease","volume":"3","author":"Asonuma","year":"1999","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib74","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/lt.25308","article-title":"Predictive factors for survival in children receiving liver transplantation for Wilson\u2019s disease: a cohort study using European liver transplant registry data","volume":"24","author":"Pfister","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/TP.0b013e3181919984","article-title":"Long-term outcomes for 32 cases of Wilson\u2019s disease after living-donor liver transplantation","volume":"87","author":"Yoshitoshi","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib76","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/lt.25304","article-title":"Liver transplantation for propionic acidemia and methymalonic acidemia: perioperative management and clinical outcomes","volume":"24","author":"Critelli","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/lt.23765","article-title":"Pediatric liver transplantation for urea cycle disorders and organic acidemias: United network for organ sharing data for 2002-2012","volume":"20","author":"Perito","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib78","first-page":"106","article-title":"Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data","volume":"15","author":"Chapman","year":"2018","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jhep.2022.10.013_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/petr.12196","article-title":"Living donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry","volume":"18","author":"Kasahara","year":"2014","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib80","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/pan.12930","article-title":"Perioperative management of living-donor liver transplantation for methylmalonic acidemia","volume":"26","author":"Baba","year":"2016","journal-title":"Pediatr Anaesth"},{"key":"10.1016\/j.jhep.2022.10.013_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-3046.2011.01607.x","article-title":"Living-donor liver transplantation for propionic acidemia","volume":"16","author":"Kasahara","year":"2012","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1067\/mpd.2002.121698","article-title":"Metabolic stroke in methylmalonic acidemia five years after liver transplantation","volume":"140","author":"Chakrapani","year":"2002","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhep.2022.10.013_bib83","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/COPD.S137852","article-title":"Alpha-1 antitripsin Pi\u2217SZ genotype: estimated prevalence and number of SZ subjects worldwide","volume":"12","author":"Blanco","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jhep.2022.10.013_bib84","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"Alfa 1-antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2022.10.013_bib85","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alfa 1-antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib86","first-page":"258","article-title":"Liver replacement for alpha1-antitrypsin deficiency","volume":"81","author":"Putnam","year":"1977","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2022.10.013_bib87","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.dld.2020.10.016","article-title":"Long term result of liver transplantation for alpha-1 antitrypsin deficiency","volume":"53","author":"Guillaud","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2022.10.013_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13075","article-title":"Massive ascites and the heterozygous alpha 1 antitripsin living related donor liver in the monozygous child","volume":"22","author":"Khorsandi","year":"2018","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib89","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.tp.0000812788.45232.66","article-title":"Liver transplantation from a heterozygous living-related donor into an alpha-1 antitrypsin deficient pediatric recipient","volume":"105","author":"Lee","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib90","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/TP.0000000000002493","article-title":"Outcomes of living-donor liver transplantation using grafts heterozygous for alpha-1 antitripsin gene mutation","volume":"103","author":"Doshi","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib91","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2022.10.013_bib92","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/21678707.2018.1495558","article-title":"Advances in understanding disease mechanisms and potential treatments for Crigler-Najjar syndrome","volume":"6","author":"Bortolussi","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.jhep.2022.10.013_bib93","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/liv.15239","article-title":"Disease burden and management of Crigler-Najjar syndrome: report of a world registry","volume":"42","author":"Aronson","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2022.10.013_bib94","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/hep.30959","article-title":"Crigler-Najjar syndrome type 1: pathophysiology, natural history, and therapeutic frontier","volume":"71","author":"Strauss","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.10.013_bib95","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1034\/j.1399-0012.2002.01140.x","article-title":"Living-related liver transplantation for Crigler-Najjar syndrome in Saudi Arabia","volume":"16","author":"Shurafa","year":"2002","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib96","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.transproceed.2009.07.025","article-title":"Living related liver transplantation in Crigler-Najjar syndrome type 1","volume":"41","author":"Ozcay","year":"2009","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2022.10.013_bib97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/j.1536-4801.1982.tb08329.x","article-title":"Prolonged neonatal jaundice: a manifestation of heterozygote state for Crigler-Najjar syndrome?","volume":"1","author":"Odievre","year":"1982","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2022.10.013_bib98","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2022.10.013_bib99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/10.supp8.3","article-title":"Epidemiology of primary hyperoxaluria type 1","volume":"10","author":"Cochat","year":"1995","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib100","first-page":"697","article-title":"Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation","volume":"57","author":"Watts","year":"1985","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.jhep.2022.10.013_bib101","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/petr.12376","article-title":"Two-step transplantation for primary hyperoxaluria: a winning strategy to prevent progression of systemic oxalosis in early onset renal insufficiency cases","volume":"19","author":"Sasaki","year":"2015","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib102","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/cs0750315","article-title":"Further studies on the activity and subcellular distribution of alanine: glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1","volume":"75","author":"Danpure","year":"1988","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhep.2022.10.013_bib103","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1542\/peds.109.6.999","article-title":"Diagnosis and treatment of maple syrup disease: a study of 36 patients","volume":"109","author":"Morton","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2022.10.013_bib104","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urinary disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhep.2022.10.013_bib105","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/petr.12736","article-title":"Heterozygous liver transplantation for maple syrup urine disease: first Euroipean reported case","volume":"20","author":"Roilides","year":"2016","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14174","article-title":"Surgical technique and long-term outcomes of pediatric living donor domino liver transplantation from patient with maple syrup urine disease","volume":"26","author":"Shimizu","year":"2022","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib107","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0000000000002300","article-title":"Domino liver transplant in maple syrup urine disease: technical details of cases in which the first surgery involved a living donor","volume":"103","author":"Roda","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2022.10.013_bib108","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1111\/petr.12439","article-title":"Heterozyote to homozygote related living donor liver transplantation in maple syrup urine disease: a case report","volume":"19","author":"Patel","year":"2015","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib109","first-page":"59","article-title":"Acute metabolic crisis in maple syrup urine disease after liver transplantation from a related heterozygous living donor","volume":"30","author":"Al-Shamsi","year":"2016","journal-title":"JIMD Rep"},{"key":"10.1016\/j.jhep.2022.10.013_bib110","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/jlts.2003.50221","article-title":"Selection of donors for living donor liver transplantation","volume":"9","author":"Trotter","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2022.10.013_bib111","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/01.TP.0000046535.49186.EB","article-title":"Evaluation of living donors","volume":"75","author":"Chen","year":"2003","journal-title":"Transplantation"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822031518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822031518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:49:52Z","timestamp":1759175392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822031518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0168827822031518"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.10.013","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of living donors for hereditary liver disease (siblings, heterozygotes)","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}